Physician profile
Jennifer Eubanks
NPI 1720241201
$44,348.28
in general payments reported to CMS, 2019-2025
78 companies · $2,629 in 2025
The $2,629 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $1,293 · 2021: $2,222 · 2022: $3,069 · 2023: $2,847 · 2024: $2,489 · 2025: $2,629.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,656 · Education: $310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,655.99 |
| Education | $309.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $28,516.24 | 2019-2025 | Polivy, Venclexta, Columvi |
| Janssen Biotech, INC. | $1,231.34 | 2019-2025 | Erleada, Akeega, Tecvayli |
| Merck Sharp & Dohme LLC | $969.21 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Pfizer INC. | $906.59 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $777.88 | 2019-2025 | Opdivo, Opdualag |
| Novartis Pharmaceuticals Corporation | $768.27 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $737.25 | 2019-2025 | Imfinzi, Enhertu, Tagrisso |
| Incyte Corporation | $704.90 | 2020-2025 | Monjuvi, Jakafi, Niktimvo |
| Celgene Corporation | $657.80 | 2019-2025 | Reblozyl, Opdualag, Pomalyst |
| Abbvie INC. | $648.80 | 2019-2025 | |
| Genzyme Corporation | $532.17 | 2019-2024 | |
| Gilead Sciences, INC. | $496.28 | 2019-2025 | Trodelvy |
| Amgen INC. | $477.93 | 2019-2023 | Lumakras, Kyprolis |
| Takeda Pharmaceuticals U.S.A., INC. | $401.66 | 2019-2025 | Fruzaqla, Iclusig, Alunbrig |
| Regeneron Healthcare Solutions, INC. | $368.63 | 2019-2025 | Libtayo |
Show all 78 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $318.08 | 2020-2025 | Enhertu, Datroway |
| Astellas Pharma US INC | $294.99 | 2019-2025 | Xtandi, Vyloy |
| Beigene USA, INC. | $283.80 | 2021-2024 | Brukinsa |
| Tosoh Bioscience, INC. | $279.00 | 2019 | |
| Emd Serono, INC. | $269.95 | 2019-2025 | Bavencio |
| Lilly USA, LLC | $261.54 | 2019-2025 | Jaypirca, Verzenio |
| Eisai INC. | $255.58 | 2019-2025 | |
| Rigel Pharmaceuticals, INC. | $252.63 | 2019-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Exelixis INC. | $225.55 | 2020-2025 | Cabometyx |
| Seagen INC. | $207.74 | 2020-2023 | Adcetris |
| Myriad Genetic Laboratories, INC. | $203.68 | 2021-2023 | Bracanalysis Cdx |
| Kite Pharma, INC. | $198.01 | 2020-2023 | Yescarta |
| Aveo Pharmaceuticals, INC. | $186.83 | 2022-2025 | Fotivda |
| Jazz Pharmaceuticals INC. | $175.12 | 2020-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $172.50 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $166.56 | 2019-2021 | |
| Array Biopharma INC | $156.80 | 2020-2025 | Braftovi, Mektovi, Xalkori |
| Puma Biotechnology, INC. | $152.76 | 2019-2025 | |
| Glaxosmithkline, LLC. | $136.51 | 2022-2025 | Jemperli, Zejula, Ojjaara |
| Ipsen Biopharmaceuticals, INC | $125.23 | 2019-2022 | |
| Karyopharm Therapeutics INC. | $124.23 | 2021-2023 | Xpovio |
| Pharmacyclics LLC, An Abbvie Company | $102.21 | 2019-2022 | |
| Stemline Therapeutics INC. | $98.09 | 2024-2025 | Orserdu |
| Octapharma USA, INC. | $86.96 | 2020 | |
| Springworks Therapeutics, INC. | $76.49 | 2024-2025 | Ogsiveo |
| Pharmaessentia USA Corporation | $74.95 | 2022-2024 | Besremi |
| Spectrum Pharmaceuticals INC. | $72.00 | 2024-2025 | Rolvedon |
| Morphosys, US INC. | $67.94 | 2021-2022 | |
| Beone Medicines USA, INC. | $67.94 | 2025 | Tevimbra, Brukinsa |
| G1 Therapeutics, INC. | $62.70 | 2022-2023 | Cosela |
| Sobi, INC | $60.46 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.33 | 2021-2022 | |
| Taiho Oncology, INC. | $54.38 | 2019-2022 | |
| Intuitive Surgical, INC. | $50.17 | 2025 | |
| Kyowa Kirin, INC. | $47.95 | 2021-2022 | |
| Foundation Medicine, INC. | $47.82 | 2022-2023 | |
| Genmab U.S., INC. | $46.99 | 2023-2025 | Tivdak, Epkinly |
| Legend Biotech USA INC. | $45.45 | 2025 | Carvykti |
| Coherus Oncology, INC. | $43.36 | 2020-2021 | |
| Bard Access Systems, INC. | $39.72 | 2019 | |
| Tersera Therapeutics LLC | $39.12 | 2021-2023 | Zoladex |
| Adc Therapeutics America, INC. | $33.75 | 2021-2023 | |
| Tesaro, INC. | $33.71 | 2019 | |
| Acceleron Pharma, INC. | $32.95 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $28.22 | 2023 | Odomzo, Yonsa |
| Secura Bio, INC. | $27.76 | 2020-2022 | |
| Agios Pharmaceuticals, INC. | $26.59 | 2019 | |
| Blueprint Medicines Corporation | $26.49 | 2020-2022 | |
| Clovis Oncology, INC. | $24.77 | 2019-2020 | |
| Tg Therapeutics, INC. | $20.92 | 2021 | |
| Dendreon Pharmaceuticals LLC | $19.43 | 2025 | Provenge |
| Mirati Therapeutics, INC. | $18.74 | 2023 | Krazati |
| Lexicon Pharmaceuticals, INC. | $18.53 | 2020 | |
| Immunomedics, INC. | $18.12 | 2020 | |
| Novocure INC. | $17.65 | 2024 | Optune Lua (Novottf-200t) |
| Geron Corporation | $17.05 | 2025 | Rytelo |
| Fresenius Kabi USA, LLC | $16.02 | 2025 | Stimufend |
| Dova Pharmaceuticals | $15.24 | 2021 | |
| Caris Mpi, INC. | $14.57 | 2025 | Mi Cancer Seek |
| Verrica Pharmaceuticals INC. | $14.23 | 2024 | Ycanth |
| Pharmacosmos Therapeutics INC. | $13.89 | 2021 | |
| Deciphera Pharmaceuticals INC. | $11.44 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $11.14 | 2019 |
Drugs and devices associated with these payments
Keytruda $458Opdivo $359Erleada $348Venclexta $326Enhertu $324Polivy $302Libtayo $299Reblozyl $291Trodelvy $289Xtandi $211Monjuvi $208Akeega $203Elahere $197Imfinzi $195Tecvayli $191Lenvima $184Tukysa $174Lynparza $172Cabometyx $171Fotivda $162Bracanalysis Cdx $158Ibrance $158Columvi $150Tavalisse $147Rezlidhia $147Brukinsa $139Darzalex $128Sarclisa $123Talzenna $118Jakafi $117Kisqali $112Braftovi $100Pluvicto $99.57Orserdu $98.09Imbruvica $97.14Welireg $87.50Orgovyx $85.20Adcetris $84.73Mektovi $81.11Balversa $78.47Talvey $77.16Zejula $75.20Jemperli $75.20Nubeqa $73.45Rybrevant $72.16Rolvedon $72.00Inlyta $71.49Fruzaqla $67.37Epkinly $65.84Lorbrena $62.00Verzenio $60.10Jaypirca $60.10Ogsiveo $58.29Paxlovid $58.05Comirnaty $58.05Besremi $56.99Scemblix $55.13Xpovio $54.75Xofigo $51.83Da Vinci Surgical System $50.17Zepzelca $47.87Opdualag $47.26Bosulif $45.62Elrexfio $45.62Carvykti $45.45Xalkori $45.03Tecentriq $39.99Lutathera $38.71Ojjaara $38.54Pomalyst $36.84Tevimbra $36.79Tagrisso $36.39Lumakras $36.24Bavencio $36.06Yescarta $34.47Tivdak $32.41Jevtana $30.59Yonsa $28.22Odomzo $28.22Datroway $27.87Ziihera $26.83Mekinist $24.41Iclusig $24.16Zoladex $23.84Gavreto $21.99Stivarga $21.62Vitrakvi $21.62Alunbrig $20.38Piqray $19.99Itovebi $19.99Promacta $19.82Provenge $19.43Doptelet $19.21Vyloy $18.93Krazati $18.74Blenrep $18.52Kyprolis $18.29Tasigna $18.18Niktimvo $17.96Optune Lua (Novottf-200t) $17.65
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Eubanks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.